Janumet XR (sitagliptin + metformin extended-release) - Merck (MSD)
Merck: Annual Report 2013 (Merck (MSD)) - Mar 19, 2014 - Anticipated compound patent expiry in US in 2022; Anticipated patent expiry on salt in US in 2026 
Anticipated patent expiry • Diabetes
http://www.merck.com/investors/financial-reports/home.html
 
Mar 19, 2014
 
.
 
08fe9030-6958-41a0-be72-586852eec5b2.jpg